-
Wed23Apr2025Fri25Apr2025
-
Thu24Apr2025Sat26Apr2025
-
Thu08May2025Sat10May2025
-
Tue20May2025
-
Wed21May2025
-
Wed04Jun2025Sat07Jun2025
-
Thu12Jun2025Fri13Jun2025
-
Thu26Jun2025Sat28Jun2025
Latest News
VenoValve: Analysis finds similar improvement among both primary and thrombotic deep...
A new subanalysis of the SAVVE (Surgical antireflux venous valve endoprosthesis) trial found that there was no difference in the level of improvement in...
Features
No longer a ‘one-trick shop’: Venous becomes core pillar of CX...
Charting the development of the Charing Cross (CX) venous and lymphatic programme from a sidebar event to becoming an “integral part” of the meeting’s...
Thrombectomy gold rush set to follow ATTRACT study, experts argue
At the recent Endo Vascular Access (EVA) meeting (14–15 June, Patras, Greece), Ziv Haskal (University of Virginia School of Medicine, Charlottesville, USA) spoke to...
Videos
Before the STEVECO trial, there were no randomized controlled trial data in the chronic disease space; in its wake, has come a more robust landscape to establish an evidence base: During the 2024 Charing Cross (CX) International Symposium (April...
